Long COVID Information and Resources
This talking points document was developed by the iREACH Subject Matter Experts to provide information and resources on long COVID-19.
FAQs on Flu Disease
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
AIM: Fertility, Pregnancy, and COVID-19 Vaccines Talking Points
This talking points document was developed by iREACH Subject Matter Experts to provide information on fertility, pregnancy and COVID-19 vaccines.
COVID-19 Vaccine Ingredients and Safety Powerpoint Presentation Template
Help your community learn more about ingredients commonly found in vaccines and the vaccine safety system in the U.S. with this customizable presentation.
COVID-19 Omicron (B.1.1.529) Variant
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the COVID-19 Omicron variant.
COVID-19 Reminder/Recall Postcard Templates
AIM developed four reminder/recall postcard templates for COVID-19 vaccine as part of the Vaccine Access and Training (VAT) project.
Infographic: Sharing COVID-19 Vaccine Facts
This iREACH infographic describes three different kinds of false information and explains how to fact check information.
AIM: Talking Points About GBS and J&J Vaccine
This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.
FDA Authorized vs FDA Approved
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.
December 2021 ACIP Recommendation on Johnson & Johnson Vaccine
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the ACIP recommendation regarding the Johnson & Johnson COVID-19 vaccine.